By : Lisa| Key words : China,COVID-19
French.china.org.cn | Updated on 22-03-2022
–
–
China has introduced antigen testing into its health insurance as an interim measure against COVID-19, according to the National Health Care Security Administration.
Those expenses which are produced in the designated basic level medical institutions should be settled according to the existing provisions of the social mutualization units, while the cost of antigen test reagents in the designated retail pharmacies can be covered by individual accounts, the administration said in an announcement Monday.
Provincial authorities will have to incorporate antigen testing reagents and related tests into their basic medical insurance service catalog, and continue to regulate the price of such services, the announcement added.
They are also asked to cover the cost of newly added drugs in the latest version of the diagnostic and treatment protocol for COVID-19 through their health insurance funds.
